đź“Š Evidence-Based Reference
metrosoft deltafilcona hydrophilic contact lenses
Metrosoft
Summary: Metrosoft Deltafilcona Hydrophilic Contact Lenses are designed for vision correction. Cleared by the FDA in 1981, they are used primarily for refractive error correction. Limited evidence is available on outcomes and safety.
FDA Clearance Information
Pathway
PMA
Number
P800013 ↗
Decision Date
September 23, 1981
Product Code
LPL
Device Class
Class 2
Evidence
419 studies
The Metrosoft Deltafilcona Hydrophilic Contact Lenses were cleared by the FDA through the PMA pathway on September 23, 1981. Manufactured by Metrosoft, they are classified as Class 2 under product code LPL.
What It Is
The Metrosoft Deltafilcona Hydrophilic Contact Lenses are soft contact lenses designed to correct refractive errors. They are hydrophilic, allowing for increased comfort and moisture retention, making them suitable for extended wear.
Clinical Applications
These contact lenses are commonly used in patients requiring vision correction for myopia, hyperopia, or astigmatism. They are particularly useful in scenarios where glasses are impractical or for aesthetic reasons.
Evidence Summary
The available literature includes 10 studies ranging from 1974 to 2023. The studies are primarily observational and descriptive, with limited data on specific outcomes or safety metrics.
Reported Outcomes
Published studies report limited data on the efficacy of Metrosoft Deltafilcona Hydrophilic Contact Lenses. The available literature does not provide detailed outcomes, focusing instead on general use and application.
Safety Profile
Reported complications include general discomfort and potential for lens spoilage, as noted in older studies. No recent comprehensive safety data is available from the provided evidence.
Evidence Limitations
The evidence is limited by the age of the studies and lack of detailed outcome measures. Further research is needed to assess long-term safety and efficacy in diverse populations.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for Metrosoft Deltafilcona Hydrophilic Contact Lenses?
The lenses are indicated for the correction of refractive errors such as myopia, hyperopia, and astigmatism.
What outcomes have been reported in clinical studies?
Specific findings are limited; studies primarily describe general use without detailed efficacy outcomes.
What complications have been reported?
Safety data from evidence includes reports of lens spoilage and general discomfort, with no recent comprehensive safety assessments.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.